These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7435587

  • 1. Protective actions of naloxone in hemorrhagic shock.
    Curtis MT, Lefer AM.
    Am J Physiol; 1980 Sep; 239(3):H416-21. PubMed ID: 7435587
    [Abstract] [Full Text] [Related]

  • 2. Beneficial action of a new opiate antagonist (Win 44,441-3) in hemorrhagic shock.
    Curtis MT, Lefer AM.
    Eur J Pharmacol; 1982 Mar 12; 78(3):307-13. PubMed ID: 6279411
    [Abstract] [Full Text] [Related]

  • 3. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
    Hock CE, Su JY, Lefer AM.
    Am J Physiol; 1984 Feb 12; 246(2 Pt 2):H174-9. PubMed ID: 6696129
    [Abstract] [Full Text] [Related]

  • 4. Actions of opiate antagonists with selective receptor interactions in hemorrhagic shock.
    Curtis MT, Lefer AM.
    Circ Shock; 1983 Feb 12; 10(2):131-45. PubMed ID: 6301706
    [Abstract] [Full Text] [Related]

  • 5. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H, Yanagisawa A, Lefer AM.
    Circ Shock; 1986 Feb 12; 20(1):1-11. PubMed ID: 2945667
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of hypertonic saline in the treatment of hemorrhagic shock.
    Bitterman H, Triolo J, Lefer AM.
    Circ Shock; 1987 Feb 12; 21(4):271-83. PubMed ID: 3581442
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
    Stahl GL, Bitterman H, Terashita Z, Lefer AM.
    Eur J Pharmacol; 1988 May 10; 149(3):233-40. PubMed ID: 3409951
    [Abstract] [Full Text] [Related]

  • 17. Reversal by naloxone of hemorrhagic shock in anephric cats.
    Feuerstein G, Ailam R, Bergman F.
    Eur J Pharmacol; 1980 Jul 11; 65(1):93-6. PubMed ID: 7398781
    [Abstract] [Full Text] [Related]

  • 18. Effect of an opiate antagonist (naloxone) and an agonist/antagonist (nalbuphine) in primate hemorrhagic shock: relationship to catecholamine release.
    McIntosh TK, Palter M, Grasberger R, Vezina R, Yeston NS, Egdahl RH.
    Circ Shock; 1985 Jul 11; 17(4):313-25. PubMed ID: 4092345
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.